| 2023-05-16 | Sale | Akebia Therapeutics, Inc. AKBA | SVP, CFO and Treasurer | 63,567 0.035% | $1.07 | $67,890 | +20% | |
| 2023-03-01 | Sale | Akebia Therapeutics, Inc. AKBA | SVP, CFO and Treasurer | 7,210 0.0038% | $0.88 | $6,327 | +23.5% | |
| 2023-02-27 | Sale | Akebia Therapeutics, Inc. AKBA | SVP, CFO and Treasurer | 7,539 0.0041% | $0.81 | $6,131 | +38.48% | |
| 2022-03-01 | Sale | Akebia Therapeutics, Inc. AKBA | SVP, CFO and Treasurer | 803 0.0005% | $2.17 | $1,743 | -80.93% | |
| 2022-02-28 | Sale | Akebia Therapeutics, Inc. AKBA | SVP, CFO and Treasurer | 7,400 0.0041% | $2.15 | $15,946 | -81.02% | |
| 2021-04-01 | Sale | Akebia Therapeutics, Inc. AKBA | SVP, CFO and Treasurer | 790 0.0005% | $3.40 | $2,686 | -15.92% |